Stryker to acquire assets of Small Bone Innovations for up to $375M cash Stryker announced a definitive agreement to acquire assets of Small Bone Innovations in an all cash transaction for up to $375M. The net cost to Stryker after taking into account the present value of the tax benefits as a result of the asset purchase structure will be up to $285M. Upon closing, the transaction is expected to be 2c dilutive to Stryker's FY14 EPS excluding acquisition, integration-related and intangible amortization charges. The transaction is expected to close in Q3.
News For SYK From The Last 14 Days
Check below for free stories on SYK the last two weeks.
Stryker upcoming analyst day may be catalyst for shares, says Argus Argus believes Stryker is well positioned to post stronger sales and earnings in the second half of the year as new products launch and surgical volume rebounds. The firm thinks the company's analyst day on September 17 could be a catalyst for the shares and it maintains its Buy rating and $102 price target on the stock.